Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report

AIDS. 2014 Aug 24;28(13):1995-7. doi: 10.1097/QAD.0000000000000387.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Drug Combinations
  • Emtricitabine
  • Histocytochemistry
  • Humans
  • Lipodystrophy / chemically induced*
  • Lipodystrophy / complications
  • Lipodystrophy / pathology
  • Male
  • Microscopy
  • Middle Aged
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / pathology
  • Muscular Atrophy, Spinal / chemically induced*
  • Muscular Atrophy, Spinal / complications
  • Muscular Atrophy, Spinal / pathology
  • Nitriles / adverse effects*
  • Nitriles / therapeutic use
  • Organophosphonates / adverse effects*
  • Organophosphonates / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Rilpivirine
  • Tenofovir

Substances

  • Drug Combinations
  • Nitriles
  • Organophosphonates
  • Pyrimidines
  • Deoxycytidine
  • Tenofovir
  • Rilpivirine
  • Emtricitabine
  • Adenine